Search Results - "Whatmore, AJ"

Refine Results
  1. 1

    A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency by CARAKUSHANSKY, Mauri, WHATMORE, Andrew J, CLAYTON, Peter E, SHALET, Stephen M, GLEESON, Helena K, PRICE, David A, LEVINE, Michael A, SALVATORI, Roberto

    Published in European journal of endocrinology (2003)
    “…Mutations in the GH-releasing hormone (GHRH) receptor (GHRHR) gene (GHRHR) cause autosomal recessive familial isolated GH deficiency (IGHD). We searched for…”
    Get full text
    Journal Article
  2. 2

    Ghrelin concentrations in healthy children and adolescents by Whatmore, A. J., Hall, C. M., Jones, J., Westwood, M., Clayton, P. E.

    Published in Clinical endocrinology (Oxford) (01-11-2003)
    “…Summary objective  In addition to its regulation by GH releasing hormone (GHRH) and somatostatin, release of GH from the pituitary is modulated by a third…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Variability in anterior pituitary size within members of a family with GH deficiency due to a new splice mutation in the GHRH receptor gene by Alba, Maria, Hall, Catherine M., Whatmore, Andrew J., Clayton, Peter E., Price, David A., Salvatori, Roberto

    Published in Clinical endocrinology (Oxford) (01-04-2004)
    “…Summary objective  Mutations in the GHRH receptor (GHRHR) gene (GHRHR) cause autosomal recessive isolated GH deficiency (IGHD), and are usually associated with…”
    Get full text
    Journal Article
  5. 5

    Serum leptin through childhood and adolescence by Clayton, Peter E., Gill, Matthew S., Hall, Catherine M., Tillmann, Vallo, Whatmore, Andrew J., Price, David A.

    Published in Clinical endocrinology (Oxford) (01-06-1997)
    “…OBJECTIVE Leptin is the protein product of the recently cloned ob gene, that has been implicated in the control of body weight and thermogenesis, but also…”
    Get full text
    Journal Article
  6. 6

    Biochemical tests in the diagnosis of childhood growth hormone deficiency by TILLMANN, V, BUCKLER, J. M. H, KIBIRIGE, M. S, PRICE, D. A, SHALET, S. M, WALES, J. K. H, ADDISON, M. G, GILL, M. S, WHATMORE, A. J, CLAYTON, P. E

    “…GH stimulation tests are widely used in the diagnosis of GH deficiency (GHD), although they are associated with a high false positive rate. We have examined,…”
    Get full text
    Journal Article
  7. 7

    Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth by TILLMANN, V, PATEL, L, GILL, M. S, WHATMORE, A. J, PRICE, D. A, KIBIRIGE, M. S, WALES, J. K, CLAYTON, P. E

    Published in Clinical endocrinology (Oxford) (01-09-2000)
    “…OBJECTIVE Serum IGF‐I levels are monitored during GH replacement treatment in adults with GH deficiency (GHD) to guide GH dose adjustment and to minimize…”
    Get full text
    Journal Article
  8. 8

    The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegaly by Parkinson, C., Whatmore, A. J., Yates, A. P., Drake, W. M., Brabant, G., Clayton, P. E., Trainer, P. J.

    Published in Clinical endocrinology (Oxford) (01-08-2003)
    “…Summary background In humans, serum leptin correlates positively with fat mass. GH is lipolytic and patients with active acromegaly have lowered serum leptin…”
    Get full text
    Journal Article
  9. 9

    GH and epidermal growth factor signaling in normal and Laron syndrome fibroblasts by Silva, Corinne M, Kloth, Michael T, Whatmore, Andrew J, Freeth, James S, Anderson, Neil, Laughlin, Kristen K, Huynh, Trang, Woodall, Alyson J, Clayton, Peter E

    Published in Endocrinology (Philadelphia) (01-07-2002)
    “…We have investigated and compared GH and epidermal growth factor (EGF) signaling in primary human skin fibroblasts from normal subjects and subjects with…”
    Get full text
    Journal Article
  10. 10

    Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific by Love, D W, Whatmore, A J, Clayton, P E, Silva, C M

    Published in Endocrinology (Philadelphia) (01-04-1998)
    “…The GH receptor is a member of the cytokine receptor superfamily. Studies in the 3T3-F442A mouse preadipocyte have shown that GH activates the Janus kinase…”
    Get full text
    Journal Article
  11. 11

    Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children by Freeth, J S, Silva, C M, Whatmore, A J, Clayton, P E

    Published in Endocrinology (Philadelphia) (01-01-1998)
    “…We have previously described two families (H and M) with GH binding protein-positive Laron Syndrome (LS), proposed to have one or more post GHR signaling…”
    Get full text
    Journal Article
  12. 12

    IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance by Das, U, Whatmore, AJ, Khosravi, J, Wales, JK, Butler, G, Kibirige, MS, Diamandi, A, Jones, J, Patel, L, Hall, CM, Price, DA, Clayton, PE

    Published in European journal of endocrinology (01-09-2003)
    “…BACKGROUND/AIM: In childhood an appropriate response to GH treatment is achieved by titration of growth response against dose administered, with careful…”
    Get full text
    Journal Article
  13. 13

    Leptin measurement in urine in children and its relationship to other growth peptides in serum and urine by Zaman, Nasra, Hall, Catherine M., Gill, Matthew S., Jones, Julie, Tillmann, Vallo, Westwood, Melissa, Whatmore, Andrew J., Clayton, Peter E.

    Published in Clinical endocrinology (Oxford) (01-01-2003)
    “…Summary objective Leptin has been implicated in the interaction between nutrition, energy balance and sexual maturation in humans. A non‐invasive method of…”
    Get full text
    Journal Article
  14. 14

    Urinary IGF and IGF binding protein-3 in children with disordered growth by Gill, M. S., Whatmore, A. J., Tillman, V., White, A., Addison, G. M., Price, D. A., Clayton, P. E.

    Published in Clinical endocrinology (Oxford) (01-04-1997)
    “…OBJECTIVE Both IGF‐l and IGFBP‐3 reflect spontaneous GH secretion in healthy individuals. We have evaluated the clinical usefulness of urinary IGF‐I and…”
    Get full text
    Journal Article
  15. 15

    Signal transduction defects in growth hormone insensitivity by Clayton, PE, Freeth, JS, Whatmore, AJ, Ayling, RM, Norman, MR, Silva, CM

    Published in Acta Paediatrica (01-02-1999)
    “…Clayton PE, Freeth JS, Whatmore AJ, Ayling RM, Norman MR, Silva CM. Signal transduction defects in growth hormone insensitivity. Acta Pædiatr 1999; Suppl 428:…”
    Get full text
    Journal Article
  16. 16

    Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome by FREETH, J. S, AYLING, R. M, WHATMORE, A. J, TOWNER, P, PRICE, D. A, NORMAN, M. R, CLAYTON, P. E

    Published in Endocrinology (Philadelphia) (1997)
    “…Congenital GH insensitivity (Laron's syndrome, LS) is often associated with a dysfunctional GH receptor (GHR) causing complete insensitivity to GH and absent…”
    Get full text
    Journal Article
  17. 17

    Insulin-like growth factor binding protein-3 generation : An index of growth hormone insensitivity by THALANGE, N. K. S, PRICE, D. A, GILL, M. S, WHATMORE, A. J, ADDISON, G. M, CLAYTON, P. E

    Published in Pediatric research (01-05-1996)
    “…GH insensitivity may be an inherited condition or may arise as a consequence of disease of malnutrition. Laron syndrome is the most severe form of GH…”
    Get full text
    Journal Article
  18. 18

    Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation by Tillmann, V, Shalet, S M, Price, D A, Wales, J K, Pennells, L, Soden, J, Gill, M S, Whatmore, A J, Clayton, P E

    Published in Hormone research (01-08-1998)
    “…The relationship between peak growth hormone (GH), insulin-like growth factor I (IGF-I), IGF-I binding protein 3 (IGFBP-3) and IGFBP-3 protease activity was…”
    Get more information
    Journal Article
  19. 19

    Infradian rhythms in urinary growth hormone excretion by THALANGE, N. K. S, GILL, M. S, GILL, L, WHATMORE, A. J, ADDISON, G. M, PRICE, D. A, CLAYTON, P. E

    “…All studies of urinary GH excretion in normal and disordered growth have revealed marked day to day (infradian) variation. We used serial overnight urinary GH…”
    Get full text
    Journal Article
  20. 20

    Glycolipids isolated from cultured rat hepatocytes: analysis of their role in insulin signal transduction by Whatmore, A J, Bate, A J, Dickson, A J

    Published in Cellular signalling (01-01-1993)
    “…The precise mechanism by which insulin elicits its effects remains to be fully determined. A glycophospholipid, isolated from H35 cells, has been proposed as a…”
    Get more information
    Journal Article